This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

This Center for Evolution and Medicine Seminar features Mitesh J. Borad, M.D., an assistant professor of medicine and director of Phase I Drug Development at Mayo Clinic in Arizona. He obtained his internal medical training at Cedars-Sinai Medical Center and completed his medical oncology fellowship at Tulane University School of Medicine. Prior to joining Mayo Clinic, he spent three years at the Translational Genomics Research Institute as a Genomics Medicine Scholar. He has been serving on the NCI Hepatobiliary Task Force since 2011.

In this special seminar the postdoctoral fellows within the Center for Evolution and Medicine will explain their research and the connection it has to evolutionary medicine.

Alexandra Greenwald is a Postdoctoral Fellow at the Center for Evolution and Medicine. Her expertise is in bioarchaeology and evolutionary anthropology, and her research focuses on breastfeeding and weaning behavior in ancient human populations. She will be giving a talk on 'Evolutionary Insights into Breastfeeding from Archaeological Populations'.